EXOSOME SHEDDING IS ASSOCIATED WITH TIME TO PROGRESSION IN NON-RESECTABLE, TRANSPLANT ELIGIBLE HCC UNDERGOING FIRST CYCLE LIVER-DIRECTED THERAPY. Article

Web of Science: 000870796600204

Cited authors

  • Nunez K, Wyczechowska D, Hibino M, Sandow T, Dash S, Thevenot P, Cohen AJ

Authors

Publication date

  • 2022

Published in

International Standard Serial Number (ISSN)

  • 0270-9139

Number of pages

  • 2

Start page

  • S179

End page

  • S180

Volume

  • 76